131 related articles for article (PubMed ID: 17989717)
1. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis.
Marton S; Garcia MR; Robello C; Persson H; Trajtenberg F; Pritsch O; Rovira C; Naya H; Dighiero G; Cayota A
Leukemia; 2008 Feb; 22(2):330-8. PubMed ID: 17989717
[TBL] [Abstract][Full Text] [Related]
2. Evolving DNA methylation and gene expression markers of B-cell chronic lymphocytic leukemia are present in pre-diagnostic blood samples more than 10 years prior to diagnosis.
Georgiadis P; Liampa I; Hebels DG; Krauskopf J; Chatziioannou A; Valavanis I; de Kok TMCM; Kleinjans JCS; Bergdahl IA; Melin B; Spaeth F; Palli D; Vermeulen RCH; Vlaanderen J; Chadeau-Hyam M; Vineis P; Kyrtopoulos SA;
BMC Genomics; 2017 Sep; 18(1):728. PubMed ID: 28903739
[TBL] [Abstract][Full Text] [Related]
3. Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations.
Liu P; Wang K; Li J; Ogasawara MA; Xia Z; Wierda WG; Keating MJ; Li Y; Huang P
Haematologica; 2024 Feb; 109(2):479-492. PubMed ID: 37646669
[TBL] [Abstract][Full Text] [Related]
4. Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients.
Farzadfard E; Kalantari T; Tamaddon G
J Blood Med; 2020; 11():97-102. PubMed ID: 32210655
[TBL] [Abstract][Full Text] [Related]
5. miRNA Biology in Chronic Lymphocytic Leukemia.
Bayraktar R; Fontana B; Calin GA; Nemeth K
Semin Hematol; 2024 Mar; ():. PubMed ID: 38724414
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia.
Ali A; Mahla SB; Reza V; Hossein A; Bahareh K; Mohammad H; Fatemeh S; Mostafa AB; Leili R
EJHaem; 2024 Feb; 5(1):191-205. PubMed ID: 38406506
[TBL] [Abstract][Full Text] [Related]
7. miR-1202 acts as anti-oncomiR in myeloid leukaemia by down-modulating GATA-1
Sessa R; Trombetti S; Bianco AL; Amendola G; Catapano R; Cesaro E; Petruzziello F; D'Armiento M; Maruotti GM; Menna G; Izzo P; Grosso M
Open Biol; 2024 Feb; 14(2):230319. PubMed ID: 38350611
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs in Chronic Lymphocytic Leukemia.
Autore F; Ramassone A; Stirparo L; Pagotto S; Fresa A; Innocenti I; Visone R; Laurenti L
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569845
[TBL] [Abstract][Full Text] [Related]
9. Antitumor Activities of Green Tea by Up-regulation of miR-181a Expression in LNCaP Cells Using 3D Cell Culture Model.
Safari F; Rayat Azad N; Alizadeh Ezdiny A; Pakizehkar S; Khazaei Koohpar Z; Ranji N
Avicenna J Med Biotechnol; 2022; 14(1):89-94. PubMed ID: 35509367
[TBL] [Abstract][Full Text] [Related]
10. TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression.
Marquez ME; Sernbo S; Payque E; Uria R; Tosar JP; Querol J; Berca C; Uriepero A; Prieto D; Alvarez-Saravia D; Oliver C; Irigoin V; Dos Santos G; Guillermo C; Landoni AI; Navarrete M; Palacios F; Oppezzo P
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406446
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles of the HECT-type E3 ubiquitin ligases in hematological malignancies.
Delvecchio VS; Fierro C; Giovannini S; Melino G; Bernassola F
Discov Oncol; 2021 Oct; 12(1):39. PubMed ID: 35201500
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs from urinary exosomes as alternative biomarkers in the differentiation of benign and malignant prostate diseases.
Holdmann J; Markert L; Klinger C; Kaufmann M; Schork K; Turewicz M; Eisenacher M; Degener S; Dreger NM; Roth S; Savelsbergh A
J Circ Biomark; 2022; 11():5-13. PubMed ID: 35173821
[TBL] [Abstract][Full Text] [Related]
13. One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies.
Kalushkova A; Nylund P; Párraga AA; Lennartsson A; Jernberg-Wiklund H
Epigenomes; 2021 Oct; 5(4):. PubMed ID: 34968247
[TBL] [Abstract][Full Text] [Related]
14. BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production.
Karabon L; Andrzejczak A; Ciszak L; Tomkiewicz A; Szteblich A; Bojarska-Junak A; Roliński J; Wołowiec D; Wróbel T; Kosmaczewska A
Cells; 2021 Nov; 10(11):. PubMed ID: 34831232
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers.
Anelli L; Zagaria A; Specchia G; Musto P; Albano F
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281210
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia.
Lin WY; Fordham SE; Sunter N; Elstob C; Rahman T; Willmore E; Shepherd C; Strathdee G; Mainou-Fowler T; Piddock R; Mearns H; Barrow T; Houlston RS; Marr H; Wallis J; Summerfield G; Marshall S; Pettitt A; Pepper C; Fegan C; Forconi F; Dyer MJS; Jayne S; Sellors A; Schuh A; Robbe P; Oscier D; Bailey J; Rais S; Bentley A; Cawkwell L; Evans P; Hillmen P; Pratt G; Allsup DJ; Allan JM
Nat Commun; 2021 Jan; 12(1):665. PubMed ID: 33510140
[TBL] [Abstract][Full Text] [Related]
17. Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia.
Fabris L; Juracek J; Calin G
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937758
[TBL] [Abstract][Full Text] [Related]
18. The Role of microRNAs in Organismal and Skin Aging.
Gerasymchuk M; Cherkasova V; Kovalchuk O; Kovalchuk I
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722415
[TBL] [Abstract][Full Text] [Related]
19. Targeting microRNA in hematologic malignancies.
Han Z; Rosen ST; Querfeld C
Curr Opin Oncol; 2020 Sep; 32(5):535-544. PubMed ID: 32657797
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
